Artemether & Lumefantrine Oral Suspension – A Powerful Duo For First Line of Defense Against Malaria.
LARITIL Dry Syrup: Artemether 20 mg + Lumefantrine 120 mg, The Dual Composition of Artemether and Lumefantrine Oral Suspension—LARITIL Dry Syrup is mainly used to treat mixed infections and primarily differs. Artemether is a fast-acting artemisinin derivative that is converted in the body to dihydroartemisinin (DHA). It generates free radicals through interaction with the parasite and damages the radicals in parasite proteins and membranes, leading to the rapid death of the parasite.
Lumefantrine is a long-acting antimalarial from the fluorene class, which inhibits the parasite’s ability to detoxify heme, which causes accumulation of toxic-free homes and offers a longer duration of action, killing remaining parasites and preventing recurrence.
Recommended By Specialists:
✅Infectious Disease Specialists: It is mainly used to differentiate for treating uncomplicated malaria, especially in travellers, returnees from endemic areas, or drug-resistant cases.
✅General Physicians: Commonly used in malaria-endemic regions or rural/primary care settings for first-line management of falciparum malaria.
Key Benefits of Artemether & Lumefantrine Oral Suspension- LARITIL Dry Syrup
✅Improved Stability and Storage: To get more stable in powder form with a good shelf life, which is ideal for tropical, rural, or resource-limited settings.
✅Double Action With Maximum Effects: Combine Artemether’s rapid parasite-killing power with its long-lasting defence to treat unbeatable malaria.
✅Two Mechanisms. One Powerful Cure: A synergistic combination targets different life stages of the malaria parasite — delivering speed, strength, and sustained protection in a single course
INDICATIONS:
✅Uncomplicated Plasmodium falciparum malaria
✅Mixed infection